l-Deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons1

Biochemical Pharmacology

Volumn 58, Issue 7, 1999, Pages 1183-1190

  Xu, Lin ^a   Ma, Jianfang ^b   Seigel, Gail M ^c   Ma, Jian xing ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Internal Medicine   (China)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Apoptosis; Deprenyl; Gene; mRNA differential display; Neuroprotection; Retina

Indexed keywords

MESSENGER RNA; SELEGILINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HYPOXIA; ISCHEMIA; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA NERVE CELL;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; DNA FRAGMENTATION; GENE EXPRESSION REGULATION; KIDNEY; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PROTECTIVE AGENTS; RATS; RETINA; RETINAL DEGENERATION; RNA, MESSENGER; SELEGILINE;

EID: 0033213838     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00208-7     Document Type: Article

References (41)

1. Vezina P., Mohr E., Grimes D. Deprenyl in Parkinson's disease Mechanisms, neuroprotective effect, indications and adverse effects . Can J Neurol Sci. 19:1992;142-146.
2. Knoll J. The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. J Neural Transm Suppl. 40:1993;69-91.
3. Birkmayer W., Riederer P., Youdim M.B.H., Linauer W. The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, deprenil. J Neural Transm. 36:1975;303-326.
4. Tetrud J.W., Langston J.W. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science. 245:1989;519-522.
5. Tatton W.G., Greenwood C.E. Rescue of dying neurons A new action for deprenyl in MPTP Parkinsonism . J Neurosci Res. 30:1991;666-672.
6. Milgram N.W., Racine R.J., Nellis P., Mendonca A., Ivy G.O. Maintenance on L-deprenyl prolongs life in aged male rats. Life Sci. 47:1990;415-420.
7. Zeng Y.C., Bongrani S., Bronzetti E., Cadel S., Ricci A., Valsecchi B., Amenta F. Effect of long-term treatment with L-deprenyl on the age-dependent microanatomical changes in the rat hippocampus. Mech Ageing Dev. 79:1995;169-185.
8. Tariot P.N., Cohen R.M., Sunderland T., Newhouse P.A., Yount D., Mellow A.M., Weingartner H., Mueller E.A., Murphy D.L. L-Deprenyl in Alzheimer's disease. Arch Gen Psychiatry. 44:1987;427-433.
9. Knoll J. Pharmacological basis of the therapeutic effect of (-)-deprenyl in age-related neurological diseases. Med Res Rev. 12:1992;505-524.
10. Roy E., Bedard P.J. Deprenyl increases survival of rat foetal nigral neurones in culture. Neuroreport. 4:1993;1183-1186.
11. Tatton W.G., Yu W.Y., Holland D.P., Tai C., Kwan M. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem. 63:1994;1572-1575.
12. Tatton WG and Chalmers-Redman RME, Modulation of gene expression rather than monoamine oxidase inhibition: (-)-Deprenyl-related compounds in controlling neurodegeneration. Neurology 47 (6 Suppl 3): S171-S183, 1996.
13. Fang J., Zuo D.M., Yu P.H. Lack of protective effect of (-)-deprenyl on programmed cell death of mouse thymocytes induced by dexamethasone. Life Sci. 57:1995;15-22.
14. Buys Y.M., Trope G.E., Tatton W.G. (-)-Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush. Curr Eye Res. 14:1995;119-126.
15. Trope GE, Williams-Lyn DE, Flanagan JG, Buys Y and Tatton WG, (-) Deprenyl improves visual function in glaucoma patients. Invest Ophthalmol Vis Sci 35 (Suppl): 2178, 1994.
16. Seigel G.M. Establishment of an E1A-immortalized retinal cell culture. In Vitro Cell Dev Biol Anim. 32:1996;6668.
17. Seigel G.M., Mutchler A.L., Adamus G., Imperato-Kalmar E.L. Recoverin expression in the R28 retinal precursor cell line. In Vitro Cell Dev Biol Anim. 33:1997;499-502.
18. 2+ associated with apoptosis. Methods Cell Biol. 46:1995;41-55.
19. Negoescu A., Lorimer P., Labat-Moleur F., Drouet C., Robert C., Guillermet C., Brambilla C., Brambilla E. In situ apoptotic cell labelling by the TUNEL method Improvement and evaluation on cell preparation . J Histochem Cytochem. 44:1996;959-968.
20. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
21. Thiry M. Highly sensitive immunodetection of DNA on sections with exogenous terminal deoxynucleotidyl transferase and non-isotopic nucleotide analogs. J Histochem Cytochem. 40:1992;411-419.
22. Ellis R.E., Yuan J.Y., Horvitz H.R. Mechanisms and functions of cell death. Annu Rev Cell Biol. 7:1991;663-698.
23. Dragunow M., Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res Brain Res Rev. 21:1995;1-28.
24. Bosman F.T., Visser B.C., van Oeveren J. Apoptosis Pathophysiology of programmed cell death . Pathol Res Pract. 192:1996;676-683.
25. Youdim M.B., Heldman E., Pollard H.B., Fleming P., McHugh E. Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 and chromaffin cells. Neuroscience. 19:1986;1311-1318.
26. Messina A., Jaworowski A., Bell C. Detection of jun but not fos protein during developmental cell death in sympathetic neurons. J Comp Neurol. 372:1996;544-550.
27. Herdegen T., Skene P., Bahr M. The c-Jun transcription factor - Bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20:1997;227-231.
28. Macaya A. Apoptosis in the nervous system. Rev Neurol. 24:1996;1356-1360.
29. Mosser D.D., Caron A.W., Bourget L., Denis-Larose C., Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 17:1997;5317-5327.
30. Filippovich I., Sorokina N., Khanna K.K., Lavin M.F. Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA. Biochem Biophys Res Commun. 198:1994;257-265.
31. Paschen W. Disturbances of calcium homeostasis within the endoplasmic reticulum may contribute to the development of ischemic-cell damage. Med Hypotheses. 47:1996;283-288.
32. Smith P.D., Moss S.E. Structural evolution of the annexin superfamily. Trends Genet. 10:1994;241-246.
33. Moss S.E. Ion channels Annexins taken to task . Nature. 378:1995;446-447.
34. Burgoyne R.D., Morgan A. Evidence for a role of calpactin in calcium-dependent exocytosis. Biochem Soc Trans. 18:1990;1101-1104.
35. McKanna J.A. Lipocortin I in apoptosis Mammary regression . Anat Rec. 242:1995;1-10.
36. Blake C.C., Rice D.W. Phosphoglycerate kinase. Philos Trans R Soc Lond B Biol Sci. 293:1981;93-104.
37. Chang G.-Q., Hao Y., Wong F. Apoptosis, Final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 11:1993;595-605.
38. Xu G.Z., Li W.W., Tso M.O. Apoptosis in human retinal degenerations. Trans Am Ophthalmol Soc. 94:1996;411-430.
39. Quigley H.A. Ganglion cell death in glaucoma Pathology recapitulates ontogeny . Aust N Z J Ophthalmol. 23:1995;85-91.
40. Garcia-Valenzuela E., Shareef S., Walsh J., Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 61:1995;33-44.
41. Nickells R.W., Zack D.J. Apoptosis in ocular disease A molecular overview . Ophthalmol Genet. 17:1996;145-165.